| Literature DB >> 35206065 |
Francesco Cairone1, Stefania Garzoli1, Luigi Menghini2, Giovanna Simonetti3, Maria Antonietta Casadei1, Laura Di Muzio1, Stefania Cesa1.
Abstract
Kiwi fruit samples (Actinidia deliciosa Planch, cv. Hayward) represent a suitable and good source for fibers obtainment as well as for polyphenolic and carotenoid extraction. With this aim, in this study they were submitted to a double phase extraction to separate insoluble fibers by an organic phase containing lipophilic substances and an hydroalcoholic phase containing polyphenols and soluble fibers. Insoluble fibers could be separated by filtration and sent to be micronized and reused. Hydroalcoholic fractions were then furtherly fractionated by solid-phase extraction. Data coming from the color CIEL*a*b* and the HPLC-DAD analyses of the extracts were compared and correlate with those coming from the SPME-GC/MS analysis of either the finely shredded peels or of the extracts. The obtained extracts were also submitted to anti-radical activity evaluation and anti-Candida activity. Results show that all of the obtained residues are value added products. Hypotheses were also made about the nature and the possible recycle of the obtained purified solid residue.Entities:
Keywords: DPPH assay; HPLC-DAD analysis; SPME-GC-MS analysis CIEL*a*b* analysis; anti-Candida activity; circular economy; kiwi peels
Year: 2022 PMID: 35206065 PMCID: PMC8871187 DOI: 10.3390/foods11040589
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1GC-MS and SPME-GC-MS analyses of the most significant components of kiwi peels and extracts.
Figure 2Scheme of peels recycling and indicative estimate of the obtained quantities.
Figure 3Colorimetric data and reflectance curves of the hydroalcoholic (HA) and organic (HE) extracts. The RSD values, evaluated on triplicates, were <5%.
Figure 4Comparison of anti-radical capacity related to different extraction methods. Values are expressed as mg equivalents of gallic acid/g of obtained extract.
Antifungal activity of kiwi samples. Activity was determined according to Clinical and Laboratory Standards Institute guidelines (CLSI document M38-A2, 2008). Minimal inhibitory concentration (MIC) was determined. MIC50, the lowest drug concentration that prevented 50% of growth with respect to the untreated control. The values shown are the median from three independent measurements).
|
|
| ||||
|---|---|---|---|---|---|
| Median MIC µg/mL | |||||
| PMC0849 | PMC0822 | PMC806 | PMC843 | ATCC24433 | |
|
| 512 | 256 | 512 | 512 | 256 |
|
| 512 | 128 | 256 | 192 | 256 |
|
| 512 | 128 | 256 | 128 | 512 |
|
| 256 | 128 | 128 | 128 | 256 |
|
| 64 | 32 | 32 | 32 | 32 |
|
| 32 | 4 | 4 | 4 | 8 |
|
| 0.5 | 0.5 | 2 | 2 | 2 |
Figure 5Example chromatograms at 280 nm of: A, hydroalcoholic extracts; B, HA-SP extracts; C, HA-EA extracts. Quantified peaks: 1, catechin; 2, epicatechin; 3, caffeic acid; 4, sinapic acid.
HPLC-DAD data of the obtained peel kiwi extracts. The results are expressed in mg/g of dry extract. BLD, below limit of detection.
| Catechin | Epicatechin | Caffeic Acid | Sinapic Acid | |
|---|---|---|---|---|
|
| 3.2 ± 0.4 | BLD | 0.5 ± 0.01 | BLD |
|
| 2.9 ± 0.1 | BLD | 0.5 ± 0.02 | BLD |
|
| 21.8 ± 3.1 | 9.4 ± 1.2 | 6.1 ± 0.8 | 1.7 ± 0.3 |
|
| 23.6 ± 4.3 | 2.8 ± 0.9 | 6.1 ± 0.6 | 1.6 ± 0.1 |
|
| 10.1 ± 2.4 | BLD | 5.9 ± 0.9 | - |
|
| 16.4 ± 1.1 | BLD | 8.3 ± 0.1 | - |